Page 264 - Read Online
P. 264

Guo et al.                                                                                                                                                     Diagnosis and treatment of cryptococcal meningitis

           Conflicts of interest                                 meningoencephalitis: correlation of MRI and pathologic findings. No
           There are no conflicts of interest.                   To Hattatsu 2003;35:499-504. (in Japanese)
                                                              14.  Loyse  A,  Wainwright  H,  Jarvis  JN,  Bicanic  T,  Rebe  K,  Meintjes
           Patient consent                                       G,  Harrison  TS.  Histopathology  of  the  arachnoid  granulations  and
                                                                 brain in HIV-associated  cryptococcal  meningitis:  correlation  with
           No patient involved.                                  cerebrospinal fluid pressure. AIDS 2010;24:405-10.
                                                              15.  Anekthananon T, Manosuthi W, Chetchotisakd P, Kiertiburanakul S,
           Ethics approval                                       Supparatpinyo K, Ratanasuwan W, Pappas PG, Filler SG, Kopetskie
           This article does not contain any studies with human   HA, Nolen TL, Kendrick AS, Larsen RA; BAMSG 3-01 Study Team.
           participants or animals.                              Predictors of poor clinical  outcome  of cryptococcal  meningitis  in
                                                                 HIV-infected patients. Int J STD AIDS 2011;22:665-70.
           REFERENCES                                         16.  Megson GM, Stevens DA, Hamilton JR, Denning DW. D-mannitol in
                                                                 cerebrospinal fluid of patients with AIDS and cryptococcal meningitis.
                                                                 J Clin Microbiol 1996;34:218-21.
           1.   Park  BJ,  Wannemuehler  KA,  Marston  BJ,  Govender  N,  Pappas  PG,   17.  Xu XG, Pan WH, Bi XL, Fang W, Chen M, Zhu Y, Zhou J, Zhou
               Chiller  TM.  Estimation  of  the  current  global  burden  of  cryptococcal   N, Pan B, Li M, Liao WQ, Qi ZT. Comparison of clinical features
               meningitis among persons living with HIV/AIDS. AIDS 2009;23:525-30.  in patients with persistent and nonpersistent cryptococcal meningitis:
           2.   Brizendine  KD, Pappas PG. Cryptococcal  meningitis:  current   twelve  years  of  clinical  experience  in  four  centers  in  China.  CNS
               approaches to management in patients with and without AIDS. Curr   Neurosci Ther 2013;19:625-31.
               Infect Dis Rep 2010;12:299-305.
           3.   Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC,   18.  Hakim  JG,  Gangaidzo  IT,  Heyderman  RS,  Mielke  J,  Mushangi  E,
                                                                 Taziwa A,  Robertson  VJ,  Musvaire  P,  Mason  PR.  Impact  of  HIV
               Longley N, Muzoora C, Phulusa J, Taseera K, Kanyembe C, Wilson   infection on meningitis in Harare, Zimbabwe: a prospective study of
               D, Hosseinipour MC, Brouwer AE, Limmathurotsakul D, White N,   406 predominantly adult patients. AIDS 2000;14:1401-7.
               van der Horst C, Wood R, Meintjes G, Bradley J, Jaffar S, Harrison T.   19.  Moosa MY, Coovadia YM. Cryptococcal meningitis in Durban, South
               Determinants of mortality in a combined cohort of 501 patients with
               HIV-associated Cryptococcal meningitis: implications for improving   Africa:  a  comparison  of  clinical  features,  laboratory  findings,  and
                                                                 outcome for human immunodeficiency virus (HIV)-positive and HIV-
               outcomes. Clin Infect Dis 2014;58:736-45.
           4.   WHO  Guidelines Approved  by  the  Guidelines  Review  Committee.   negative patients. Clin Infect Dis 1997;24:131-4.
               Rapid advice: diagnosis, prevention, and management of cryptococcal   20.  Makadzange AT, McHugh G. New approaches to the diagnosis and
               disease in HIV-infected  adults, adolescents  and children.  Geneva:   treatment of cryptococcal meningitis. Semin Neurol 2014;34:47-60.
               World Health Organization; 2011 Dec.           21.  Boulware DR, Rolfes MA, Rajasingham R, von Hohenberg M, Qin
           5.   Brizendine KD, Baddley JW, Pappas PG. Predictors of mortality and   Z, Taseera K, Schutz C, Kwizera R, Butler EK, Meintjes G, Muzoora
               differences in clinical  features among patients  with cryptococcosis   C, Bischof JC, Meya DB. Multisite validation of cryptococcal antigen
               according to immune status. PLoS One 2013;8:e60431.  lateral flow assay and quantification by laser thermal contrast. Emerg
           6.   Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME,   Infect Dis 2014;20:45-53.
               Gardner T,  Sattah  M,  de  Leon  GP,  Baughman W,  Hajjeh  RA. The   22.  Kisenge PR, Hawkins AT, Maro VP, McHele JP, Swai NS, Mueller
               changing epidemiology of cryptococcosis: an update from population-  A,  Houpt  ER.  Low  CD4  count  plus  coma  predicts  cryptococcal
               based active surveillance in 2 large metropolitan areas, 1992-2000.   meningitis in Tanzania. BMC Infect Dis 2007;7:39.
               Clin Infect Dis 2003;36:789-94.                23.  Abassi M, Boulware DR, Rhein J. Cryptococcal meningitis: diagnosis
           7.   Rothe  C,  Sloan  DJ,  Goodson  P,  Chikafa  J,  Mukaka  M,  Denis  B,   and management update. Curr Trop Med Rep 2015;2:90-9.
               Harrison T, van Oosterhout JJ, Heyderman RS, Lalloo DG, Allain T,   24.  Perfect  JR,  Dismukes  WE,  Dromer  F,  Goldman  DL,  Graybill  JR,
               Feasey NA. A prospective longitudinal study of the clinical outcomes   Hamill  RJ,  Harrison  TS,  Larsen  RA,  Lortholary  O,  Nguyen  MH,
               from cryptococcal meningitis following treatment induction with 800   Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC. Clinical
               mg oral fluconazole in Blantyre, Malawi. PLoS One 2013;8:e67311.  practice guidelines for the management of cryptococcal disease: 2010
           8.   Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth   update by the infectious diseases society of america. Clin Infect Dis
               S, Zumla A. Clinical presentation,  natural  history, and cumulative   2010;50:291-322.
               death rates of 230 adults with primary cryptococcal  meningitis  in   25.  Fan XH, Feng GD, Yang YN, Dai W, Zhao G. Diagnostic value of
               Zambian AIDS patients treated under local conditions. Postgrad Med   May-Grunwald-Giemsa  staining  of  cerebrospinal  fluid  in  patients
               J 2001;77:769-73.                                 with cryptococcal meningitis. J Int Neurol Neurosurg 2013;40:221-2.
           9.   Lesser RL, Simon RM, Leon H, Siegel N. Cryptococcal meningitis   26.  He JY, He HY, Meng ZH, Jin BF. Disscussion of early diagnosis and
               and internal ophthalmoplegia. Am J Ophthalmol 1979;87:682-7.  curative effect of cryptococcal meningitis (30 cases report). Zhongguo
           10.  Kestelyn  P,  Taelman  H,  Bogaerts  J,  Kagame  A,  Abdel  Aziz  M,   Shen Jing Jing Shen Ji Bing Za Zhi 2007;33:433-5.
               Batungwanayo  J,  Stevens  AM,  Van  de  Perre  P.  Ophthalmic   27.  Rhein J, Boulware DR. Prognosis and management of cryptococcal
               manifestations of infections with Cryptococcus neoformans in patients   meningitis in patients with human immunodeficiency virus infection.
               with  the  acquired  immunodeficiency  syndrome.  Am  J  Ophthalmol   Neurobehav HIV Med 2012;4:45-61.
               1993;116:721-7.                                28.  Jarvis  JN,  Lawn  SD,  Vogt  M,  Bangani  N,  Wood  R,  Harrison  TS.
           11.  Sloan DJ, Parris  V. Cryptococcal meningitis:  epidemiology  and   Screening for cryptococcal  antigenemia in patients accessing an
               therapeutic options. Clin Epidemiol 2014;6:169-82.  antiretroviral  treatment  program in South  Africa.  Clin Infect  Dis
           12.  Kovoor JM, Mahadevan A, Narayan JP, Govindappa SS, Satishchandra   2009;48:856-62.
               P,  Taly  AV,  Shankar  SK.  Cryptococcal  choroid  plexitis  as  a  mass   29.  Longley  N,  Jarvis  JN,  Meintjes  G,  Boulle  A,  Cross  A,  Kelly  N,
               lesion: MR imaging  and histopathologic  correlation.  AJNR Am  J   Govender  NP,  Bekker  LG,  Wood  R,  Harrison  TS.  Cryptococcal
               Neuroradiol 2002;23:273-6.                        antigen  screening  in  patients  initiating  ART  in  South  Africa:  a
           13.  Ueda  H,  Toribe  Y,  Kuwae  Y,  Takeuchi  M,  Nakayama  M,  Ida   prospective cohort study. Clin Infect Dis 2016;62:581-7.
               S,  Okamoto  N,  Suzuki  Y.  An  autopsy  case  of  cryptococcal   30.  Temstet A, Roux P, Poirot JL, Ronin O, Dromer F. Evaluation of a
                           Neuroimmunology and Neuroinflammation ¦ Volume 3 ¦ November 18, 2016           255
   259   260   261   262   263   264   265   266   267   268   269